Parmax Pharma Ltd vs Tyche Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Parmax Pharma Ltd is ₹ 30.02 as of 30 Apr 15:30 . The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tyche Industries Ltd changed from 8.7 on March 2021 to 11 on March 2025 . This represents a CAGR of 4.80% over 5 years The Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 yearsThe Market Cap of Tyche Industries Ltd changed from ₹ 174.66 crore on March 2021 to ₹ 136.38 crore on March 2025 . This represents a CAGR of -4.83% over 5 years The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The revenue of Tyche Industries Ltd for the Dec '25 is ₹ 12.43 crore as compare to the Sep '25 revenue of ₹ 16.81 crore. This represent the decline of -26.06% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The ebitda of Tyche Industries Ltd for the Dec '25 is ₹ 2.94 crore as compare to the Sep '25 ebitda of ₹ 2.52 crore. This represent the growth of 16.67% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Tyche Industries Ltd changed from ₹ 2.73 crore to ₹ 1.82 crore over 7 quarters. This represents a CAGR of -20.68% The Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tyche Industries Ltd changed from 5.13 % on March 2021 to 24.78 % on March 2025 . This represents a CAGR of 37.02% over 5 years .

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

About Tyche Industries Ltd

Tyche Industries Limited was initially incorporated as Siris Soft Limited on July 23, 1998.
The Company changed the name to 'Tyche Industries Limited' with due approval from the RoC in 2004.
TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe.
Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
The company has three business models namely offshore solutions, offsite solutions and onsite solutions.

FAQs for the comparison of Parmax Pharma Ltd and Tyche Industries Ltd

Which company has a larger market capitalization, Parmax Pharma Ltd or Tyche Industries Ltd?

Market cap of Parmax Pharma Ltd is 11 Cr while Market cap of Tyche Industries Ltd is 125 Cr

What are the key factors driving the stock performance of Parmax Pharma Ltd and Tyche Industries Ltd?

The stock performance of Parmax Pharma Ltd and Tyche Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parmax Pharma Ltd and Tyche Industries Ltd?

As of May 4, 2026, the Parmax Pharma Ltd stock price is INR ₹30.02. On the other hand, Tyche Industries Ltd stock price is INR ₹122.92.

How do dividend payouts of Parmax Pharma Ltd and Tyche Industries Ltd compare?

To compare the dividend payouts of Parmax Pharma Ltd and Tyche Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.